TARTAGLIONE, Immacolata
 Distribuzione geografica
Continente #
EU - Europa 1.571
AS - Asia 1.001
NA - Nord America 975
SA - Sud America 199
AF - Africa 18
OC - Oceania 2
Totale 3.766
Nazione #
US - Stati Uniti d'America 954
RU - Federazione Russa 671
SG - Singapore 376
IE - Irlanda 296
IT - Italia 255
CN - Cina 217
HK - Hong Kong 201
BR - Brasile 164
DE - Germania 102
GB - Regno Unito 78
KR - Corea 50
VN - Vietnam 47
JP - Giappone 32
IN - India 29
UA - Ucraina 29
FR - Francia 25
GR - Grecia 22
FI - Finlandia 18
AR - Argentina 17
SE - Svezia 14
AT - Austria 13
PK - Pakistan 11
BD - Bangladesh 10
BE - Belgio 10
CA - Canada 10
NL - Olanda 10
CH - Svizzera 8
MX - Messico 8
TR - Turchia 7
ZA - Sudafrica 7
ID - Indonesia 6
EC - Ecuador 5
VE - Venezuela 5
CO - Colombia 4
ES - Italia 4
DZ - Algeria 3
IL - Israele 3
PL - Polonia 3
AU - Australia 2
CI - Costa d'Avorio 2
CL - Cile 2
CZ - Repubblica Ceca 2
MA - Marocco 2
NI - Nicaragua 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
HU - Ungheria 1
IQ - Iraq 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
PH - Filippine 1
PS - Palestinian Territory 1
TW - Taiwan 1
Totale 3.766
Città #
Dublin 287
Moscow 220
Hong Kong 201
Santa Clara 167
Singapore 166
Chandler 122
Jacksonville 66
Seoul 50
Caserta 43
Beijing 42
New York 41
Princeton 38
Roxbury 38
Ann Arbor 36
Bremen 33
Hefei 33
Munich 32
Naples 32
Ashburn 30
Grumo Nevano 21
Cambridge 20
Dallas 20
Ercolano 20
Bengaluru 19
Medford 19
Ho Chi Minh City 17
The Dalles 17
Wilmington 17
Woodbridge 17
Des Moines 13
Nuremberg 12
Los Angeles 11
Nanjing 11
Boardman 10
Brussels 10
Rome 10
São Paulo 10
Hanoi 9
Helsinki 9
Milan 9
Vienna 9
Amsterdam 8
London 8
Napoli 8
Pozzuoli 8
Falkenstein 7
Redwood City 7
Brooklyn 6
Johannesburg 6
Nanchang 6
Turku 6
Belo Horizonte 5
Montreal 5
Orlando 5
Rio de Janeiro 5
Bologna 4
Campinas 4
Curitiba 4
Da Nang 4
Fairfield 4
Salvador 4
San Mateo 4
Shanghai 4
Taizhou 4
Tokyo 4
Aversa 3
Biên Hòa 3
Boston 3
Brasília 3
Chicago 3
Guangzhou 3
Istanbul 3
Mexico City 3
Quito 3
Ribeirão Preto 3
Shenyang 3
Stockholm 3
Tianjin 3
Abidjan 2
Araraquara 2
Asunción 2
Bandung 2
Belgrade 2
Bogotá 2
Brno 2
Buenos Aires 2
Caracas 2
Caxias do Sul 2
Council Bluffs 2
Dourados 2
Elora 2
Guayaquil 2
Haiphong 2
Harbin 2
Kunming 2
Lahore 2
Leawood 2
Managua 2
Manchester 2
Osasco 2
Totale 2.200
Nome #
Cognitive, Brain and Intracranial Artery Involvement in Beta Thalassemia 171
Effects of germline VHL deficiency on growth, metabolism, and mitochondria 162
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. 126
Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload 126
Auditory cortex hypoperfusion: a metabolic hallmark in Beta Thalassemia 115
Asymptomatic intracranial aneurysms in beta-thalassemia: A three-year follow-up report 109
Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study 105
A Novel 12q13.2-q13.3 Microdeletion Syndrome With Combined Features of Diamond Blackfan Anemia, Pierre Robin Sequence and Klippel Feil Deformity 101
Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience 99
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multicentre nation-wide cohort 99
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort 98
BONE MINERAL DENSITY IMPROVEMENT IN PATIENTS WITH THALASSEMIA MAJOR ON LONG-TERM CHELATION THERAPY WITH DEFERASIROX 97
Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy 96
Brain functional impairment in beta-thalassaemia: the cognitive profile in Italian neurologically asymptomatic adult patients in comparison to the reported literature 96
No evidence of increased cerebrovascular involvement in adult neurologically-asymptomatic β-Thalassaemia. A multicentre multimodal magnetic resonance study 93
An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research 93
Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function 92
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort 90
A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis 88
Crushed deferasirox film-coated tablets in pediatric patients with transfusional hemosiderosis: Results from a single-arm, interventional phase 4 study (MIMAS) 78
Headache in beta-thalassemia: An Italian multicenter clinical, conventional MRI and MR-angiography case-control study 78
Long-term efficacy of deferasirox for cardiac siderosis in thalassemia major 77
Childhood Multiple Endocrine Neoplasia (MEN) Syndromes: Genetics, Clinical Heterogeneity and Modifying Genes 75
Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: a retrospective cohort study of A.I.E.O.P. patients (Associazione Italiana Emato-Oncologia Pediatrica) 75
Long term efficacy of iron chelation therapy with deferasirox on endocrine function in thalassemia major 75
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia. 75
Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with beta-thalassemia. 73
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection 73
Brain perfusion changes in beta-thalassemia 70
Transient erythroblastopenia of childhood after COVID-19 infection: a case report 70
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-Thalassemia. 68
No increased cerebrovascular involvement in adult beta-thalassemia by advanced MRI analyses 66
GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia 64
White matter volume changes in adult beta-thalassemia: Negligible and unrelated to anemia and cognitive performances 64
Hearing loss in beta-thalassemia: Systematic review 64
Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds 59
Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and Ghana 58
Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: Phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study 56
Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence 53
Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies 52
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization 50
Hearing loss in beta-thalassaemia: An Italian multicentre case-control study 48
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial 48
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry 48
Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited 46
Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia 44
Renal safety under long-course deferasirox therapy in iron overloaded transfusion-dependent β-thalassemia and other anemias 39
Pain Frequency and Health Care Utilization Patterns in Women with Sickle Cell Disease Experiencing Menstruation-Associated Pain Crises 31
Pregnancy and childbirth in women with thalassemia: past and present 31
Cognitive impairment in hereditary spherocytosis 29
Totale 3.893
Categoria #
all - tutte 16.988
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.988


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202188 0 0 0 0 0 16 22 6 6 12 24 2
2021/2022279 6 4 5 4 61 10 31 25 18 7 20 88
2022/2023578 55 22 22 28 57 54 3 19 287 7 13 11
2023/2024235 19 7 18 14 63 47 4 5 5 0 19 34
2024/2025878 2 7 5 20 131 102 166 86 131 81 87 60
2025/20261.438 128 152 176 172 345 465 0 0 0 0 0 0
Totale 3.893